In collaboration with RMIT University, Snoretox is developing the world’s first injectable solution to treat obstructive sleep apnoea and other conditions involving low muscle tone.
Our game-changing technology is based on molecules of tetanus toxin, modified to ensure they work around the tetanus vaccine.
Just as Botox uses tiny amounts of botulinum toxin to relax muscles, our prototype therapeutic uses minute amounts of safe modified tetanus toxin to achieve the opposite effect – muscle toning.
Company Details
- Employees
- 8
- Address
- Plenty Rd, Bundoora,victoria 3083,australia
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://snoretox.com/
- HQ
- Bundoora, Victoria
Snoretox Ltd Questions
Snoretox Ltd's website is https://snoretox.com/
Snoretox Ltd's LinkedIn profile is https://au.linkedin.com/company/snoretox-pty-ltd
Snoretox Ltd has
8 employees.
View email and phone details for 8
employees at Snoretox Ltd.
Snoretox Ltd's industry is
Biotechnology Research
Snoretox Ltd's top competitors are
Onecup Ai,
Astra Therapeutics,
Misti,
Invion Limited,
Peptidus Biotech,
Arthrolase,
Tessara Therapeutics,
Ovum Ai,
Adracard,
Eqcell Inc..
Snoretox Ltd's categories are Biotechnology Research
